Live news related to IPSEN stock (FR0010259150): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Ipsen announces the co-option of Peter Guenter as a board member effective from January 28, 2026, filling the vacancy created by the departure of Henr…
Ipsen's stock fell 1.22% on Wednesday, closing at 137.70 euros after reaching 139.40 euros the day before. Nevertheless, the pharmaceutical company's …
Ipsen announces the appointment of Pierrick Lefranc as Executive Vice President and member of the Executive Committee effective April 1, 2026.
BNP Paribas Exane ajuste sa position sur le titre Ipsen ce lundi 26 janvier 2026.
The French biopharmaceutical group Ipsen has prevailed in the International Chamber of Commerce (ICC) Arbitration Tribunal, which dismissed Galderma's…
Ipsen's stock has performed well over the past seven days, rising by 6.16% to close at 134.50 euros. This rebound follows Wednesday's major announceme…
Ipsen advances 4.55% to 133.30 euros this Wednesday, breaking through its resistance at 131.60 euros following the FDA's Breakthrough Therapy designat…
The biopharmaceutical group unveiled 14 scientific communications on various movement disorders at the Madrid congress, according to the statement rel…
The U.S. regulator has awarded the 'Breakthrough Therapy' designation to Ipsen's IPN60340, an experimental monoclonal antibody for patients with acute…
French laboratory Ipsen announced that the US Food and Drug Administration has granted 'Breakthrough Therapy' designation to its drug candidate IPN603…
